Your browser doesn't support javascript.
loading
Advance in animal model and therapeutic drugs for progressive muscular dystrophy / 中国药理学通报
Chinese Pharmacological Bulletin ; (12): 16-21, 2022.
Article in Chinese | WPRIM | ID: wpr-1014165
ABSTRACT
Progressive muscular dystrophy is an X-linked recessive hereditary degenerative disease caused by dystrophin gene defects, and there is currently no effective treatment.With the further study of progressive muscular dystrophy, a series of animal models have been developed to evaluate the efficacy of drugs, such as muscular dystrophy protein deficiency mice, double gene knockout Duchenne muscular dystrophy phenotype mice, muscular dystrophy dogs and zebrafish muscular dystrophy models.A variety of therapeutic strategies and dmgs are under development, such as inhibition of nonsense mutations, exon hopping therapy, gene therapy, calcium toxicity relieving drugs and antioxidants.This article reviews the pathogenesis, establishment and evaluation of animal models and the therapeutic drngs of progressive muscular dystrophy.

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: Chinese Pharmacological Bulletin Year: 2022 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: Chinese Pharmacological Bulletin Year: 2022 Type: Article